Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZIMMER BIOMET HOLDINGS, INC.

(ZBH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Zimmer Biomet Announces New Appointments to Executive Leadership Team

06/07/2021 | 08:30am EDT

Zimmer Biomet Holdings, Inc. announced two new appointments to the Company's Executive Leadership Team. Wilfred van Zuilen has been appointed as President of Europe, Middle East and Africa (EMEA). Additionally, Nitin Goyal, M.D. has been appointed to the newly created role of Chief Science, Technology and Innovation Officer. Both roles will report into Chief Operating Officer Ivan Tornos. Mr. van Zuilen will be responsible for the marketing, sales and distribution of products, services and solutions in the EMEA region. Prior to joining Zimmer Biomet, Mr. van Zuilen served as Regional Vice President, North Western Europe (United Kingdom, Ireland, Nordics and Benelux) at Medtronic. Prior to that, he led Medtronic's Restorative Therapies Group of businesses for EMEA and has also held regional leadership positions with Covidien, Novartis and Edwards Lifesciences. Mr. van Zuilen will be responsible for the marketing, sales and distribution of products, services and solutions in the EMEA region. In his newly created role, Dr. Goyal will oversee advanced research, product development, and Zimmer Biomet's innovation platforms. In addition, he will have oversight of Medical Education, Clinical Affairs and healthcare provider collaboration.


ę S&P Capital IQ 2021
All news about ZIMMER BIOMET HOLDINGS, INC.
09/15ZIMMER BIOMET : Announces Key Additions to 'NewCo' Leadership Team, Transaction to Form Ne..
AQ
09/14ZIMMER BIOMET : Names Finance Chief for Company Spin-Off
MT
09/14ZIMMER BIOMET : Announces Key Additions to "NewCo" Leadership Team; Transaction to Form Ne..
PR
09/14Zimmer Biomet Holdings, Inc. Announces Executive Changes
CI
09/14Zimmer Biomet Holdings, Inc. Appoints Richard J. Heppenstall as Chief Financial Officer
CI
09/03ZIMMER BIOMET : Maintains Q3 Cash Dividend at $0.24 a Share, Payable Oct. 29 to Shareholde..
MT
09/03ZIMMER BIOMET : To Pay Q3 Dividend
MT
09/03ZIMMER BIOMET : Announces Quarterly Dividend for Third Quarter of 2021
PR
09/03Zimmer Biomet Holdings, Inc. Announces Quarterly Dividend for Third Quarter of 2021, Pa..
CI
08/31Zimmer Biomet Holdings, Inc. Announces New Data Supporting Clinical Benefits of Mymobil..
CI
More news
Analyst Recommendations on ZIMMER BIOMET HOLDINGS, INC.
More recommendations
Financials (USD)
Sales 2021 8 099 M - -
Net income 2021 972 M - -
Net Debt 2021 6 473 M - -
P/E ratio 2021 31,8x
Yield 2021 0,66%
Capitalization 30 428 M 30 428 M -
EV / Sales 2021 4,56x
EV / Sales 2022 4,16x
Nbr of Employees 20 000
Free-Float 66,7%
Chart ZIMMER BIOMET HOLDINGS, INC.
Duration : Period :
Zimmer Biomet Holdings, Inc. Technical Analysis Chart | ZBH | US98956P1021 | MarketScreener
Technical analysis trends ZIMMER BIOMET HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 31
Last Close Price 145,70 $
Average target price 188,07 $
Spread / Average Target 29,1%
EPS Revisions
Managers and Directors
Bryan C. Hanson Chairman, President & Chief Executive Officer
Suketu P. Upadhyay Chief Financial Officer & Executive Vice President
Zeeshan Tariq Chief Information Officer & Senior Vice President
Nitin Goyal Chief Science, Technology & Innovation Officer
Ivan Tornos Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
ZIMMER BIOMET HOLDINGS, INC.-5.44%30 428
ABBOTT LABORATORIES13.85%220 982
MEDTRONIC PLC10.05%173 488
BECTON, DICKINSON AND COMPANY2.63%73 750
HOYA CORPORATION28.03%61 504
SARTORIUS STEDIM BIOTECH80.15%56 765